Surgery for advanced oropharyngeal cancer
- Authors: Karpenko A.V.1, Sibgatullin R.R.1, Boyko A.A.1, Chumanikhina N.S.1, Lomteva E.Y.2, Lavrova M.V.2, Kostova M.G.1, Nikolayeva O.M.1
-
Affiliations:
- Leningrad Regional Oncologic Dispensary.
- Leningrad Regional Clinical Hospital.
- Issue: Vol 8, No 3 (2018)
- Pages: 37-45
- Section: DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORS
- Published: 07.11.2018
- URL: https://ogsh.abvpress.ru/jour/article/view/359
- DOI: https://doi.org/10.17650/2222-1468-2018-8-3-37-45
- ID: 359
Cite item
Full Text
Abstract
The study objective is to assess the results of this approach and identifications of factors that may influence the effectiveness of such an approach.
Materials and methods. Since 2009 through 2016 72 patients with stage III and IV aged between 42 and 77 years underwent upfront surgery.Anatomical sites included 34 (46 %) tonsil, 24 (33 %) base of tongue and 14 (21 %) soft palate cases. Transcervical sparing the mandible,mandibulectomy and transoral approaches were used in 42 (58 %), 11 (15 %) and 7 (10 %) patient, respectively. Total glossectomy was performed in 4 (5.5 %) cases. Tumor extension necessitated extended laryngectomy in 8 patients (11.5 %). Primary closure of the pharyngeal wound was possible in 30 patients (42 %). Reconstruction with distant flaps was performed in the remaining 42 patients. Both free (anterolateral thigh – 19, radial forearm flap – 10) and flaps with axial blood supply (pectoralis major – 9, supraclavicular flap – 4) were used. There were 6 T1, 12 T2, 28 T3 and 20 T4 tumors; 62 patients were N-positive: N1 – 10 cases, N2 – 51, N3 – 1. Positive surgical margins were diagnosed in 13 cases (18 %) including 3 cases of R2 resection. Adjuvant radiation therapy with or without chemotherapy was completed in 45 patients (63.4 %). Survival was calculated according to Kaplan–Mayer method.
Results. There was 1 death in early postoperative period. Mean follow-up for the remaining patients (n = 71) was 27 months (1–94). Median survival was 27 months (95 % CI 11.5–42.5); 3-year overall survival was 44 %; 33 out of 34 still alive patients are capable to take food orally. Only 1 (2.9 %) patient is gastrostomy tube dependent. Univariate analysis revealed that positive margins (p <0.0001) and completeness of combined treatment (p <0.01) are the main factors that have statistically significan impact on prognosis.
Conclusion. Combined approach with upfront surgery is one of the main treatment modalities for advanced oropharyngeal cancer. Modern reconstructive options and strict adherence to a proper surgical technique give a high chance for a valuable rehabilitation for the vast majority of patients. Scrupulous planning of the resection of the primary tumor based on modern imaging techniques and encouraging patients to complete all prescribed treatments are the main physician-related factors that influence survival outcome.
About the authors
A. V. Karpenko
Leningrad Regional Oncologic Dispensary.
Email: fake@neicon.ru
ORCID iD: 0000-0002-4756-1310
37 Liteyny Ave., Saint Petersburg 191104. Russian Federation
R. R. Sibgatullin
Leningrad Regional Oncologic Dispensary.
Email: fake@neicon.ru
ORCID iD: 0000-0003-3219-4420
37 Liteyny Ave., Saint Petersburg 191104. Russian Federation
A. A. Boyko
Leningrad Regional Oncologic Dispensary.
Email: fake@neicon.ru
ORCID iD: 0000-0003-1400-7775
37 Liteyny Ave., Saint Petersburg 191104. Russian Federation
N. S. Chumanikhina
Leningrad Regional Oncologic Dispensary.
Email: fake@neicon.ru
ORCID iD: 0000-0002-0398-7491
37 Liteyny Ave., Saint Petersburg 191104. Russian Federation
E. Yu. Lomteva
Leningrad Regional Clinical Hospital.
Email: fake@neicon.ru
ORCID iD: 0000-0002-6969-6988
45–49 Lunacharskogo Ave., Saint Petersburg 194291. Russian Federation
M. V. Lavrova
Leningrad Regional Clinical Hospital.
Email: fake@neicon.ru
ORCID iD: 0000-0002-1820-7849
45–49 Lunacharskogo Ave., Saint Petersburg 194291. Russian Federation
M. G. Kostova
Leningrad Regional Oncologic Dispensary.
Author for correspondence.
Email: kostova.90@mail.ru
ORCID iD: 0000-0003-4597-184X
37 Liteyny Ave., Saint Petersburg 191104. Russian Federation
O. M. Nikolayeva
Leningrad Regional Oncologic Dispensary.
Email: fake@neicon.ru
ORCID iD: 0000-0003-3658-4493
37 Liteyny Ave., Saint Petersburg 191104. Russian Federation
References
Supplementary files


